Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shijiazhuang Junlebao Dairy is a leading Chinese dairy enterprise that has evolved into a major player in the nutrition and health sectors. The company specializes in the production of infant formula, high-end yogurt, and liquid milk, supported by a vertically integrated industrial chain. A significant portion of its business is driven by the Junlebao Nutrition Research Institute, which focuses on maternal and infant nutrition, probiotic strain development, and clinical validation of functional foods. Junlebao has successfully commercialized proprietary probiotic strains like Lactobacillus paracasei N1115, targeting digestive and immune health. The company is recognized for its rigorous quality standards and has received significant investment from global firms like Sequoia China and Hillhouse Capital. Currently, Junlebao is expanding its footprint in the life sciences space through advanced research into the human microbiome and specialized nutritional products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shijiazhuang Junlebao Dairy.